sábado, 11 de febrero de 2012


Today, we are analyzing the presence of the pharma sector in Social Media. From that, we find two very different groups of companies

The first one is integrated by GlaxoSmithKline (GSK), Sanofi, Novartis and Pfizer, which has beat for an integral presence strategy with open profiles in Facebook, Twitter, YouTube & Linkedin. In all the cases their profiles are managed at corporate level.

Novartis, with an integral strategy and very mature presence has chosen the 140 characters twitter timeline, with more than 20.000 followers and multimedia contents on YouTube with 1.216 suscriptors and more than 293.000 views from 2009. In Spain Novartis has also a set of vertical portals by pathology, reserved only for registered doctors, where they share wide information about products, training, news and services.

GSK on their side preferred Facebook as their main site, where welcome us with their guidelines policy of use, “How we operate on Facebook”, getting us informed with corporate and institutional content

Sanofi US has a big initiative on YouTube called SanofiTV, both in French & English share corporate, health, professional and CSR content.

Pfizer surpassing 40.000 fans on Facebook, has an exclusive initiative called Think Science Now, open community where researchers and scientifics share their knowledge with the entire world. In Spain they run a close group on Facebook with 372 members.

A second group its formed by Rovi, KernPharma, Alter, ALK Abello, Grifols, Zeltia, PharmaMar y Lacer. All of them has chosen Linkedin as their first step of their presence in the social media world, with a very incipient presence in most of the cases, with recents profiles on Facebook and almost without presence on Twitter, YouTube or Flickr

As a trends summary from the use of Social Media on that sector, we can conclude:

  • General social media commitment is taken from the big laboratories, Novartis, GSK, Sanofi y Pfizer.
  • All the rest has started and are on initial steps to spread their presence.
  • OTC products area are not present with promotional actions
  • Contents are fully address to physician and sanitary people
  • Facebook : Timeline closed to fans comments
  • Twitter: Use as a news channel to physician
  • YouTube: Corporate information, training, and CSR channel
  • Linkedin: Emphasize that all the analyzed companies are present on that site. With a high number of employees registered, what give us an idea of the chance for internal promotion of social media as a tool for brand positioning through our people. Several groups.
  • Not much blogs referred on each web, with Think Science Now from Pfizer as one element to take in account.
  • Very segmented approach from Novartis through their vertical portals by pathology, and their physician community «Médicos Premier» 

Although this is a sector with high reputational risk, there is a full social media commitment as a key tool within the communication plan.

From Social Media Tailored we recommend to start it an cover the four deployment steps process to set up a proper Social Media Plan: Analysis, Design, Execution and Control

Best regards

Jesús Labrado Fernández

Follow us on facebook http://www.facebook.com/SocialMediaTailored
Follow us on Linkedin http://www.linkedin.com/company/social-media-tailored

1 comentario:

  1. Thank you for sharing valuable information. Nice post. I enjoyed reading this post. The whole blog is very nice found some good stuff and good information here,Thanks..Also visit my page market access jobs .